Insider Transactions in Q1 2023 at Gossamer Bio, Inc. (GOSS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2023
|
Faheem Hasnain President & CEO |
BUY
Open market or private purchase
|
Indirect |
440,500
+8.92%
|
$440,500
$1.14 P/Share
|
|
Mar 21
2023
|
Faheem Hasnain President & CEO |
BUY
Open market or private purchase
|
Indirect |
269,389
+6.23%
|
$269,389
$1.2 P/Share
|
|
Mar 20
2023
|
Faheem Hasnain President & CEO |
BUY
Open market or private purchase
|
Indirect |
168,683
+4.27%
|
$168,683
$1.03 P/Share
|
|
Mar 20
2023
|
Bryan Giraudo COO/CFO |
BUY
Open market or private purchase
|
Indirect |
50,000
+41.33%
|
$0
$0.97 P/Share
|
|
Mar 20
2023
|
Waage Christian EVP, Tech Ops and Admin |
BUY
Open market or private purchase
|
Indirect |
18,500
+36.35%
|
$18,500
$1.2 P/Share
|
|
Mar 16
2023
|
Caryn Peterson EVP, Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
7,564
-12.32%
|
$7,564
$1.1 P/Share
|
|
Mar 16
2023
|
Richard Aranda Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,563
-3.65%
|
$7,563
$1.1 P/Share
|
|
Mar 16
2023
|
Laura Carter Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,029
-7.33%
|
$6,029
$1.1 P/Share
|